Medication-assisted Therapy (MAT) also known as Medication-assisted Recovery (MAR) is the use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders.
Medications used in MAT are approved by the Food and Drug Administration (FDA) and MAT programs are clinically driven and tailored to meet each patient’s needs.
A medication-assisted opioid treatment program uses specially approved medications to counteract the effects of opioids and help control the intense cravings that quitting initially brings. These FDA approved products are:
All of the medications listed are one of three types of medication: buprenorphine, methadone or naltrexone. Each one serving a different purpose:
Buprenorphine – suppresses and reduces cravings for opioids.
Methadone – reduces opioid cravings and withdrawal and blunts or blocks the effects of opioids.
Naltrexone – blocks the euphoric and sedative effects of opioids and prevents feelings of euphoria.
Become Waivered to Prescribe
Become a Buprenorphine waivered practitioner by clicking here. Qualified practitioners include physicians, Nurse Practitioners (NPs), Physician Assistants (PAs), Clinical Nurse Specialists (CNSs), Certified Registered Nurse Anesthetist (CRNAs), and Certified Nurse-Midwifes (CNMs).
The IME Addictions Access Center is designed to assure effective access to treatment for New Jersey residents who seek treatment for their substance use disorder.
An individual who calls the program’s toll-free number, 844-276-2777 for a referral to treatment will be provided with assistance and support on a 24/7/365 basis. Program staff provides a coordinated point of entry for those seeking treatment for a SUD. Clients calling the program will be screened and referred to a treatment provider by a warm handoff whenever possible. IME Addictions Access Center staff will assist callers to find the right provider for their needs and help them navigate the treatment network.